St. Francis Hospital, New York
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, St. Francis Hospital, New York sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
St. Francis Hospital, New York: 5 sponsored US clinical trials, 2 recruiting.
St. Francis Hospital, New York sponsors 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 2 completed. 2 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Bypass Graft Stenosis, with 1 trials.
Upper-quartile sponsor footprint
St. Francis Hospital, New York sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
The STAND-UP Study
NCT07195903
Optical Coherence Tomography of the Saphenous Vein Graft
NCT05129228
Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting
NCT04621461
Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting
NCT04370782
The Saint Francis Remote Ischemic Preconditioning Trial (SaFR)
NCT01078272
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 2 |
Therapeutic Areas
Where St. Francis Hospital, New York enrollment is open (later-stage tilt)
2 recruiting of 5 indexed (40% open); 2 completed (40%).
Phase mix: 2 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Coronary Bypass Graft Stenosis (1 trial), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
St. Francis Hospital, New York: open-pipeline peers nationwide
Peers matched on 5 registered trials and 40% open enrollment, not the therapeutic-area sidebar.
St. Francis Hospital, New York sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 40% open enrollment (± trial volume)
- Ad scientiam · 40% recruiting · 5 trials
- Alto Neuroscience · 40% recruiting · 10 trials
- Bonafide Health · 40% recruiting · 5 trials
- Brooks Rehabilitation · 40% recruiting · 5 trials
Related
What to do with this St. Francis Hospital, New York page
5 registered trials is a research-attention snapshot, not an endorsement of St. Francis Hospital, New York or any single study.
- 2 of St. Francis Hospital, New York's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Bypass Graft Stenosis is the condition St. Francis Hospital, New York studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Bypass Graft Stenosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
St. Francis Hospital, New York pipeline card: 5 registered trials from official public datasets.Report a data error.